Plant-based Excipients Market Size & Growth Forecast 2027–2036, By Segments (Chemical Nature, Applications and Function), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Plant-based Excipients Market size was over USD 2.2 billion in 2026 and is likely to grow at a 4.09% CAGR between 2027 and 2036, attaining USD 3.28 billion by 2036. The industry revenue for 2027 is calculated at USD 2.28 billion.
Get more details on this report
Request Free Sample ReportPlant-based Excipients Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 40.81% of the market in 2026, supported by a strong pharmaceutical manufacturing base, validated ingredient systems, and consistent demand for plant-derived excipients in large-scale production.
- Asia Pacific is projected to grow at a 5.02% CAGR as pharmaceutical manufacturing expands, domestic production increases, and plant-derived excipients gain wider adoption in high-volume formulations.
Segment Momentum
- Carbohydrates held a 22.78% share in 2026 because they provide versatile plant-derived excipients that support tablet structure, formulation stability, and efficient pharmaceutical manufacturing across multiple dosage forms.
- Film Forming & Coating Agents are expanding fastest as pharmaceutical manufacturers increasingly prioritize protective coatings, improved swallowability, surface protection, and product differentiation in finished dosage forms.
Market Expansion Drivers
- Rising demand for vegan pharmaceuticals driving adoption of plant-derived excipients in drug formulations.
- Regulatory support for animal-free and halal-compliant drug ingredients boosting market penetration.
- Pharmaceutical R&D expansion accelerating innovation in natural excipient-based drug delivery systems.
Leading Market Participants
- Prominent companies in the plant-based excipients market include Roquette Frères (France), BASF SE (Germany), Lonza Group AG (Switzerland), DFE Pharma (Germany), Evonik Industries AG (Germany), JRS Pharma GmbH & Co. KG (Germany), Ashland Inc. (United States), Croda International Plc (United Kingdom), International Flavors & Fragrances Inc. (United States), Colorcon Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.2 billion
- 2027 Estimated Market Size: USD 2.28 billion.
- Projected Market Size: USD 3.28 billion by 2036
- Growth Forecast: 4.09% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Carbohydrates (Chemical Nature) | Binders & Diluents (Applications and Function)
- Emerging Opportunity Segment: Carbohydrates (Chemical Nature) | Film Forming & Coating Agents (Applications and Function)
Market Growth Drivers and Industry Trends
Rising demand for vegan pharmaceuticals driving adoption of plant-derived excipients in drug formulations
The plant-based excipients market is gaining momentum as pharmaceutical manufacturers respond to growing consumer and patient preference for vegan and animal-free medicines. Plant-derived excipients can provide functional roles such as binding, coating, thickening, stabilization, and controlled release while aligning formulations with clean-label and ethical sourcing expectations. Their suitability for tablets, capsules, oral liquids, and other dosage forms allows drug developers to replace certain animal-derived ingredients without compromising formulation functionality, while the expanding availability of botanical and renewable raw materials supports broader incorporation into pharmaceutical development.
Regulatory support for animal-free and halal-compliant drug ingredients boosting market penetration
Regulatory and quality considerations surrounding animal-derived pharmaceutical ingredients are encouraging manufacturers to evaluate alternative excipient sources, supporting the plant-based excipients market. Demand is particularly relevant for formulations intended for populations and markets where halal compliance and avoidance of animal-derived materials are important purchasing or formulation considerations. Plant-based ingredients can simplify sourcing decisions by reducing concerns associated with animal origin, traceability, and religious compliance, while clearer expectations around ingredient safety, quality, and documentation encourage pharmaceutical producers to integrate suitable plant-derived excipients into commercial formulations.
Pharmaceutical R&D expansion accelerating innovation in natural excipient-based drug delivery systems
Expansion of pharmaceutical research and formulation development is creating new opportunities for the plant-based excipients market through greater exploration of naturally sourced functional materials. Researchers are investigating plant-derived polymers, fibers, gums, starches, and other materials for applications including controlled drug release, improved solubility, enhanced stability, and targeted delivery. Continued formulation research can also improve the consistency, processing characteristics, and performance of natural excipients, enabling their use in increasingly sophisticated dosage forms and supporting the development of drug delivery platforms that rely on renewable and biocompatible materials.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing use of plant-based excipients in pharmaceuticals | 1.50% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Fast |
| Adoption in nutraceutical and functional food formulations | 1.50% | Medium term (2–5 yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Moderate |
| Development of sustainable and certified excipients | 1.40% | Long term (5+ yrs) | North America, Europe (spillover: Asia Pacific) | High | Slow |
| Rising demand for vegan pharmaceuticals driving adoption of plant-derived excipients in drug formulations | 2.00% | High | North America, Europe | High | Mid Term |
| Regulatory support for animal-free and halal-compliant drug ingredients boosting market penetration | 1.80% | High | Asia Pacific, Middle East | High | Mid Term |
| Pharmaceutical R&D expansion accelerating innovation in natural excipient-based drug delivery systems | 1.50% | Moderate | North America, Asia Pacific | Medium | Long Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America led the plant-based excipients market with a 40.81% share in 2026, supported by a well-established pharmaceutical and nutraceutical manufacturing base and strong demand for naturally derived formulation ingredients. The region benefits from increasing preference for clean-label and plant-origin products, particularly as pharmaceutical manufacturers seek excipients that align with evolving consumer expectations around sustainability and ingredient transparency. Advanced formulation capabilities, established regulatory frameworks, and investments in drug development further strengthen the adoption of plant-based excipients. In addition, the expanding use of botanical and functional ingredients in dietary supplements and other health-focused products creates a broader application base for these excipients.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is positioned as the fastest-growing regional market, driven by expanding pharmaceutical production, rising healthcare expenditure, and increasing consumption of nutraceutical and wellness products. The region's large population base and growing middle-class consumer segment are encouraging greater demand for pharmaceutical formulations and supplements incorporating naturally sourced ingredients. Increasing manufacturing capabilities across emerging pharmaceutical hubs, together with improving supply-chain infrastructure and greater awareness of clean-label formulations, is supporting regional adoption. The growing emphasis on domestic pharmaceutical manufacturing and development of innovative formulations is also expected to create favorable opportunities for plant-based excipient suppliers.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Pharmaceutical Quality StandardsGermany emphasizes plant-based excipients that meet rigorous pharmaceutical quality and manufacturing requirements. German suppliers invest in validated production processes and documentation to support formulation consistency across prescription and over-the-counter products.
France 🇫🇷
Botanical Sourcing ExpertiseFrance leverages expertise in botanical ingredients to support pharmaceutical excipient development using plant-derived materials. French manufacturers emphasize traceable sourcing and formulation performance that aligns with evolving industry quality expectations.
Italy 🇮🇹
Natural Ingredient ProcessingItaly combines botanical processing capabilities with pharmaceutical manufacturing to expand plant-based excipient availability. Italian producers focus on ingredient purity, functional consistency, and collaboration with formulation developers seeking naturally derived alternatives.
Japan 🇯🇵
Functional Ingredient InnovationJapan develops plant-based excipients with improved stability, controlled release, and compatibility for advanced pharmaceutical formulations. Japanese manufacturers focus on formulation efficiency while maintaining stringent quality expectations for healthcare applications.
South Korea 🇰🇷
Biopharma Ingredient ExpansionSouth Korea is increasing the adoption of plant-based excipients alongside growth in pharmaceutical manufacturing and biopharmaceutical development. Local suppliers strengthen formulation support services and diversify botanical ingredient portfolios for drug manufacturers.
United States 🇺🇸
Natural Formulation DemandThe U.S. plant-based excipients market is expanding as pharmaceutical manufacturers incorporate naturally derived ingredients into oral and topical formulations. Companies in the U.S. prioritize functional performance, regulatory compliance, and dependable botanical raw material sourcing.
Segment Leadership and Growth Trends
Plant-based Excipients Market Share (%), by Chemical Nature, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportChemical Nature Segment Analysis: Carbohydrates (Largest & Fastest-Growing Segment)
Carbohydrates accounted for the largest share of the plant-based excipients market in 2026 and are also the fastest-growing chemical nature segment, reflecting their broad functionality and established role in pharmaceutical formulations. Plant-derived carbohydrates are widely used to provide properties such as binding, bulking, disintegration, and controlled handling of active ingredients, making them suitable for diverse dosage forms. Growing interest in naturally sourced excipients, together with pharmaceutical manufacturers' focus on functional and formulation-compatible ingredients, continues to strengthen demand for carbohydrate-based excipients.
Applications and Function Segment Analysis: Binders & Diluents (Largest Segment) vs Film Forming & Coating Agents (Fastest-Growing Segment)
The binders & diluents segment held the largest share of the plant-based excipients market in 2026, supported by the essential role these excipients play in achieving the desired physical characteristics and manufacturability of pharmaceutical dosage forms. They help improve tablet integrity, consistency, and processing performance while also enabling appropriate formulation volumes and handling properties. The growing adoption of plant-derived pharmaceutical ingredients is supporting demand for these established functions as manufacturers seek effective alternatives with strong formulation compatibility.
Film forming & coating agents are experiencing the fastest growth as pharmaceutical manufacturers increasingly focus on improving dosage-form stability, appearance, protection, and controlled release characteristics. Plant-based materials can provide functional coating properties while aligning with the industry's broader interest in naturally derived and sustainable formulation components. Increasing development of advanced oral dosage forms and greater attention to patient-friendly formulations are supporting wider use of plant-based film-forming and coating technologies.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Chemical Nature | Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Ethers & Carboxylic Acids, Others | Carbohydrates | Carbohydrates |
| Applications and Function | Binders & Diluents, Glidants, Lubricants & Disintegrants, Film Forming & Coating Agents, Plasticizers, Suspending Agents, Preservatives & Antioxidants, Colorants & Flavoring Agents | Binders & Diluents | Film Forming & Coating Agents |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Prominent players in the plant-based excipients market:
1. Roquette Frères (France)
2. BASF SE (Germany)
3. Lonza Group AG (Switzerland)
4. DFE Pharma (Germany)
5. Evonik Industries AG (Germany)
6. JRS Pharma GmbH & Co. KG (Germany)
7. Ashland Inc. (United States)
8. Croda International Plc (United Kingdom)
9. International Flavors & Fragrances Inc. (United States)
10. Colorcon Inc. (United States)
The plant-based excipients market is evolving through a noticeable shift toward cleaner formulations and naturally derived functional ingredients that align with modern formulation needs. Innovation activity is increasingly focused on expanding application versatility across pharmaceuticals and nutraceuticals, supported by ongoing development of new excipient functionalities. Collaborative development efforts and continuous product enhancements are enabling broader substitution of synthetic components, improving both safety profiles and regulatory alignment. Rising preference for plant-derived inputs is further reinforcing reformulation strategies, encouraging suppliers to differentiate through performance consistency and sourcing transparency within the plant-based excipients market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Roquette Frères (France) | |||||||
| BASF SE (Germany) | |||||||
| Lonza Group AG (Switzerland) | |||||||
| DFE Pharma (Germany) | |||||||
| Evonik Industries AG (Germany) | |||||||
| JRS Pharma GmbH & Co. KG (Germany) | |||||||
| Ashland Inc. (United States) | |||||||
| Croda International Plc (United Kingdom) | |||||||
| International Flavors & Fragrances Inc. (United States) | |||||||
| Colorcon Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Roquette | Nov-25 | Roquette showcased its plant-based excipient portfolio and dosage technologies designed to support formulation of nutrient-dense supplements for consumers using GLP-1 therapies. The development highlights the company's continued focus on multifunctional, plant-derived excipients that enable more adaptable and sustainable nutraceutical formulations. |
| JRS PHARMA | Nov-22 | JRS PHARMA launched LUBRITAB RBW, an all-natural plant-based excipient developed as a lubricant for tablet and capsule formulations. Compatible with direct compression, continuous manufacturing, and dry or wet granulation processes, the product expands the company's portfolio of naturally derived pharmaceutical excipients. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Plant-based Excipients Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Dosage Form | Tablets, Capsules, Liquid & Oral Suspensions, Topical & Semi-Solid, Other Dosage Forms |
| Source Plant | Cellulose-Based, Starch-Based, Gum-Based, Algae-Based, Other Plant Sources |
| End-use Industry | Pharmaceutical, Nutraceutical, Biopharmaceutical, Other Healthcare Applications |
Plant-based Excipients Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Pharmaceutical Formulation Adoption Assessment |
|
| Plant-Derived Ingredient Sourcing Strategy |
|
| Biopharma Application Opportunity Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow big is the plant-based excipients market?
What is the expected industry size of plant-based excipients by 2036?
How are regulatory and clean-label pressures reshaping excipient selection strategies in pharmaceutical formulation development?
What is driving the growing use of plant-based excipients in advanced drug delivery and pharmaceutical R&D pipelines?
Why are carbohydrates the leading chemical nature segment in the plant-based excipients market?
Why are film forming and coating agents the fastest-growing application in the plant-based excipients market?
Why does North America lead the plant-based excipients market?
What factors are driving Asia Pacific's growth in the plant-based excipients market?
Who are the major participants shaping the plant-based excipients landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization